Jupiter Bioscience Ltd vs ULTRATECH CEMENT LIMITED

A side-by-side comparison of Jupiter Bioscience Ltd (JUPITER) and ULTRATECH CEMENT LIMITED (ULTRACEMCO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Jupiter Bioscience Ltd vs ULTRATECH CEMENT LIMITED are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation22
  • Profitability22
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
40.53
0.00
P/B ratio
4.44
0.00%
Dividend yield
2.05%
₹8.23
EPS
₹277.10

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

8.14%
Return on equity
11.20%
8.00%
Return on capital
13.00%
44.00%
EBITDA margin
19.00%
15.41%
Net margin
9.25%

Growth

JUPITER takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

29.05%
Revenue CAGR (3Y)
11.86%
19.35%
Profit CAGR (3Y)
17.30%

Size & financial health

ULTRACEMCO takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹3.36L Cr
₹331 Cr
Revenue
₹88,512 Cr
₹51 Cr
Net profit
₹8,188 Cr
0.00
Debt / equity
0.27
Jupiter Bioscience Ltd
  • + ["Stock is trading at 0.03 times its book value", "Company has delivered good profit growth of 22.8% CAGR over last 5 years"]
  • ["Tax rate seems low", "Company has a low return on equity of 9.58% over last 3 years."]
ULTRATECH CEMENT LIMITED
  • + ["Company has been maintaining a healthy dividend payout of 51.1%"]
  • ["Stock is trading at 4.46 times its book value", "Company has a low return on equity of 10.7% over last 3 years."]
Jupiter Bioscience Ltd full analysis ULTRATECH CEMENT LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.